Larimar Therapeutics (LRMR) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

LRMR is expected to report earnings to rise 28.50% to -30 cents per share on March 12

Larimar Therapeutics LRMR Stock Earnings Reports

Q4'24

Est.

$-0.31

Q3'24

Beat

by $0.13

Q2'24

Missed

by $0.03

Q1'24

Missed

by $0.03

Q4'23

Missed

by $0.05

The last earnings report on October 30 showed earnings per share of -23 cents, beating the estimate of -37 cents. With 1.17M shares outstanding, the current market capitalization sits at 266.07M.

View a ticker or compare two or three

Compare

LRMR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LRMR
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for LRMR (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Three Bala Plaza East

Phone

+1 844 511-9056

Employees

Web

https://www.larimartx.com